Add-On Nivolumab Extends DFS in Locally Advanced Head and Neck Cancer

(MedPage Today) — CHICAGO – The postoperative addition of nivolumab (Opdivo) to chemoradiotherapy (CRT) extended disease-free survival (DFS) in certain patients with locally advanced head and neck squamous cell carcinoma (HNSCC), according…

Source link : https://www.medpagetoday.com/meetingcoverage/asco/115840

Author :

Publish date : 2025-06-01 21:35:00

Copyright for syndicated content belongs to the linked Source.

M	T	W	T	F	S	S
						1
2	3	4	5	6	7	8
9	10	11	12	13	14	15
16	17	18	19	20	21	22
23	24	25	26	27	28	29
30

Add-On Nivolumab Extends DFS in Locally Advanced Head and Neck Cancer

In Pancreatic Cancer, Does New PAXG Beat Out mFOLFIRINOX?

This Diet Pattern Is Linked With Worse Survival in Colon Cancer

Related Posts

Atezolizumab + Chemo Improves Colon Cancer Survival

Football Training Benefits Patients With Heart Issues

PARP-ARPI Combo Sets New Standard for Metastatic Hormone-Sensitive Prostate Cancer

GLP-1 Less Frequent Dosing May Maintain Weight Loss

Inexpensive HIV Med Improves Vision in Diabetic Eye Disease

Does Initial Progression of SSc-ILD Mean More Is to Come?

Football Training Benefits Patients With Heart Issues

PARP-ARPI Combo Sets New Standard for Metastatic Hormone-Sensitive Prostate Cancer

GLP-1 Less Frequent Dosing May Maintain Weight Loss

Inexpensive HIV Med Improves Vision in Diabetic Eye Disease

Does Initial Progression of SSc-ILD Mean More Is to Come?

Quarter of people follow rules even with no downside to breaking them

Rigosertib Shows Promise in EB-Associated Skin Cancer

Calls for specialist unit in Northern Ireland

Categories

Archives